Metrospaces Seeks Beta Testers for MetroHouse, MetroCrowd Platforms
NEW YORK, NY / ACCESSWIRE / October 28, 2021 / Metrospaces, Inc. (OTC PINK:MSPC), a…
NEW YORK, NY / ACCESSWIRE / October 28, 2021 / Metrospaces, Inc. (OTC PINK:MSPC), a…
6% of Guild of Guardians’ in-game currency tokens are to be sold in an exclusive…
American Manganese Successfully Completes All Identified Milestones in the DLA Project Scope of Work Within…
The CEO of Viking Fence Co. sat down to discuss his life, his career, and…
LUND, SWEDEN / ACCESSWIRE / October 28, 2021 / BioInvent International (STO:BINV) “The powerful combination…
NYKÖPING, SE / ACCESSWIRE / October 28, 2021 / CTT Systems AB (STO:CTT) THIRD QUARTER…
LUND, SWEDEN / ACCESSWIRE / October 28, 2021 / BioInvent International (STO:BINV) Lund, Sweden, October…
NEW YORK, NY / ACCESSWIRE / October 28, 2021 / The Glimpse Group, Inc. (NASDAQ:VRAR)(FSE:9DR)…
DUBLIN, IRELAND / ACCESSWIRE / October 28, 2021 / CRH plc, the leading building materials…
Launch of industry initiative to deliver requirements-informed blueprints for Enterprise and Industry 4.0 London, UK…
Join Ambulance Services from across Europe to see how technology is shaping the future of…
New payments platform gives care agencies a quick, safe, and simple way for staff to…
UKCloud’s commitment to sustainable technology will help the UK achieve net zero carbon emissions by…
Reissue to media channels, no changes to the content. Company annoucement no. 12October 28, 2021…
Press Release 28 October 2021 Immunicum AB (publ) Interim Report July – Sep 2021 FINANCIAL…
PRESS RELEASE Commercial Adoption of Herdscreen® ASFV Antibody Test in Europe New pen-side test allows…
Oslo, Norway, 28th of October 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Paris, October 28, 2021 Strong Q3 performance drives guidance upgrade to around 14% business EPS…
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATION28 OCTOBER 2021, 07:00 CEST MDxHealth Announces Launch of Proposed…
– U.S. and Japan commercial teams fully staffed ahead of potential launches of efgartigimod in…